Literature DB >> 11763426

A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.

D M Ho1, C Y Hsu, T T Wong, H Chiang.   

Abstract

Optimal histologic criteria for the classification of and grading of ependymomas, including their anaplastic forms, remain elusive. This is especially true because of the poor correlation of these criteria with clinical outcome. The aim of this study was to identify the histopathologic parameters that could distinguish different prognostic groups of patients with ependymomas. Eighty-one patients with ependymal tumors, including those originally diagnosed ependymomas, anaplastic ependymomas and myxopapillary ependymomas, were enrolled in this study. Thirteen histologic parameters, including hypercellularity, nuclear pleomorphism, mitoses, endothelial proliferation, necrosis, clear cell, thrombi, dystrophic calcification, psammoma bodies, bone, cartilage, Rosenthal fibers and MIB-1 labeling index (LI), were evaluated in each patient and correlated with clinical outcome. We assigned one score for each histopathologic parameter evaluated and used a stepwise selection method with entry model based on the significance of the log-rank statistic to formulate a scoring model. Four parameters were chosen in this process, including mitoses > or = 4/10 hpf (1.7/mm2), hypercellularity, endothelial proliferation and necrosis. The sum of these four parameters (scores) was the histopathologic score of the tumor. The progression-free survival (PFS) and overall survival (OS) of patients with histopathologic scores 0 and 1 were significantly better than those with histopathologic scores 2, 3 and 4 (p < 0.001 and p = 0.005, respectively). Because of the latter finding, we proposed that anaplastic ependymoma could be diagnosed by the presence of any two of the aforementioned four parameters. Multivariate analyses including clinical and histopathologic variables showed that histopathologic score > or = 2 and subtotal resection were the factors related to increased risk of recurrence, while histopathologic score > or = 2 was the only factor related to overall survival. Based on the above findings, we concluded that histopathology is an important prognostic indicator for patients with ependymomas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11763426     DOI: 10.1023/a:1012590505236

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  26 in total

Review 1.  Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

Authors:  E Bouffet; G Perilongo; A Canete; M Massimino
Journal:  Med Pediatr Oncol       Date:  1998-06

2.  Lack of histopathological correlation of malignant ependymomas with postoperative survival.

Authors:  G W Ross; L J Rubinstein
Journal:  J Neurosurg       Date:  1989-01       Impact factor: 5.115

3.  Relationship of morphology of ependymoma in children to prognosis.

Authors:  L B Rorke
Journal:  Prog Exp Tumor Res       Date:  1987

4.  Ependymomas: a clinicopathologic study.

Authors:  C E Rawlings; F Giangaspero; P C Burger; D E Bullard
Journal:  Surg Neurol       Date:  1988-04

5.  Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases.

Authors:  D Figarella-Branger; D Gambarelli; C Dollo; B Devictor; A M Perez-Castillo; L Genitori; G Lena; M Choux; J F Pellissier
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Prognostic factors in intracranial ependymomas in children.

Authors:  D Figarella-Branger; M Civatte; C Bouvier-Labit; J Gouvernet; D Gambarelli; J C Gentet; G Lena; M Choux; J F Pellissier
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

7.  Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.

Authors:  R A Prayson
Journal:  Mod Pathol       Date:  1997-04       Impact factor: 7.842

8.  Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas.

Authors:  L Bennetto; N Foreman; B Harding; R Hayward; J Ironside; S Love; D Ellison
Journal:  Neuropathol Appl Neurobiol       Date:  1998-12       Impact factor: 8.090

9.  Ependymomas: MIB-1 proliferation index and survival.

Authors:  A M Ritter; K R Hess; R E McLendon; L A Langford
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

10.  Ependymomas. Factors in clinical and diagnostic staging.

Authors:  C R West; D A Bruce; P K Duffner
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

View more
  18 in total

1.  Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors.

Authors:  J L Jaremko; L B O Jans; L T Coleman; M R Ditchfield
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-10       Impact factor: 3.825

2.  Pediatric anaplastic parenchymal ependymoma: case report.

Authors:  Murat Kutlay; Ahmet Cetinkal; Serdar Kaya; Mehmet N Demircan; Murat Velioglu; Ufuk Berber
Journal:  Childs Nerv Syst       Date:  2010-11-26       Impact factor: 1.475

Review 3.  Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis.

Authors:  Klara Kuncova; Ales Janda; Pavel Kasal; Josef Zamecnik
Journal:  Pathol Oncol Res       Date:  2009-03-20       Impact factor: 3.201

4.  Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.

Authors:  Rebecca Senetta; Clelia Miracco; Salvatore Lanzafame; Luigi Chiusa; Rosario Caltabiano; Antonio Galia; Giulia Stella; Paola Cassoni
Journal:  Neuro Oncol       Date:  2010-11-08       Impact factor: 12.300

5.  Rare histological variants in ependymomas: histopathological analysis of 13 cases.

Authors:  Marco Gessi; Klaus Kuchelmeister; Libero Lauriola; Torsten Pietsch
Journal:  Virchows Arch       Date:  2011-07-27       Impact factor: 4.064

Review 6.  Giant cell ependymoma of the cervical spinal cord: case report and review of the literature.

Authors:  Giuseppe M V Barbagallo; Rosario Caltabiano; Giuseppe Parisi; Vincenzo Albanese; Salvatore Lanzafame
Journal:  Eur Spine J       Date:  2008-09-27       Impact factor: 3.134

Review 7.  Survival following treatment for intracranial ependymoma: a review.

Authors:  G Tamburrini; M D'Ercole; B L Pettorini; M Caldarelli; L Massimi; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2009-04-22       Impact factor: 1.475

Review 8.  Metaplastic bone formation in a low grade conus glioma: case report and review of the literature.

Authors:  Vitaly Siomin; Robert Willinsky; Patrick Shannon; Abhijit Guha
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

9.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

10.  Anaplastic ependymoma simulating glioblastoma in the cerebrum of an adult.

Authors:  Masayuki Shintaku; Kenji Hashimoto
Journal:  Brain Tumor Pathol       Date:  2011-07-16       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.